Wedbush raised its price target on Rivian shares to $30 from $25 as the company’s production difficulties improve.

Analyst Chris Dendrinos initiated coverage of the electric and hydrogen power company with an outperform rating.

Chinese technology giant Alibaba on Friday launched Tongyi Wanxiang, an artificial intelligence tool that can generate images from prompts.

Leqembi is the first Alzheimer’s antibody treatment to receive full FDA approval.

KeyBanc downgraded the stock to sector weight from overweight on account of the company’s shares recently exceeding its previous price target of $468.

There are concerns that some companies are increasing their prices more than is needed to compensate for higher costs, thereby boosting their profit margins.

“The United States will, in certain circumstances, need to pursue targeted actions to protect its national security,” U.S. Treasury Secretary Yellen said.

Germany says it opposes sending cluster munitions to Ukraine, a day after U.S. officials suggested Washington was considering sending the weapons to Kyiv.

Starting Aug. 1, companies in China that want to export two metals used in semiconductor manufacturing would need to apply for licenses.

Janet Yellen’s visit to China is “crucial” to ensuring that both countries continue talking to each other, said Eswar Prasad of Cornell University.